Lung Cancer

Top Story

Risk for COVID-19 may be higher among those with cancer, Wuhan data suggest

March 26, 2020

Read the Perspective from Alexander Kutikov, MD, FACS

In the Journals

Targeted therapy shows promise for HER2-mutant NSCLC, other solid tumors

March 25, 2020
The novel HER2-targeted antibody-drug conjugate fam-trastuzumab deruxtecan-nxki appeared active in a cohort of patients with various heavily pretreated HER2-expressing…

Durvalumab plus chemotherapy, without tremelimumab, extends OS in small cell lung cancer

March 17, 2020
The addition of durvalumab to a choice of standard-of-care first-line chemotherapies conferred a sustained OS benefit for patients with extensive-stage small cell lung…
FDA News

FDA grants breakthrough therapy designation to JNJ-6372 for lung cancer subset

March 11, 2020
The FDA granted breakthrough therapy designation to JNJ-6372 for the treatment of certain patients with metastatic non-small cell lung cancer, according to the…
More Headlines »
Special Issue Article

Review of Cystic Fibrosis

Pediatric Annals, April 2019, Volume 48 Issue 4
Cystic fibrosis (CF) is an autosomal recessive disease characterized by pancreatic insufficiency and chronic…
More »
Meeting News Coverage

Selumetinib plus docetaxel fails to extend survival in KRAS–mutant NSCLC

October 11, 2016
COPENHAGEN, Denmark — The addition of selumetinib to second-line docetaxel did not improve outcomes among…
More »
Meeting News

VIDEO: Gefitinib may ‘change the paradigm’ to treat lung cancer

August 10, 2017
More »
Healio Jobs